Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Healthcare
Insight Molecular Diagnostics Inc. PS Ratio 2015–2026
Current and historical P/S ratio for Insight Molecular Diagnostics Inc. (IMDX): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 38.41.
From: 09/30/2020To: 03/31/2026
Stock Price
TTM Revenue
PS Ratio
Insight Molecular Diagnostics Inc. PS Ratio — FAQ
Insight Molecular Diagnostics Inc. (IMDX) ps ratio over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMDX's ps ratio history?
The chart and table above show Insight Molecular Diagnostics Inc.'s ps ratio by year and by quarter, including the growth rate.